These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31521416)

  • 41. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homozygous familial hypercholesterolemia: Summarized case reports.
    Widhalm K; Benke IM; Fritz M; Geiger H; Helk O; Fritsch M; Hoermann G; Kostner G
    Atherosclerosis; 2017 Feb; 257():86-89. PubMed ID: 28126585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.
    Kolansky DM; Cuchel M; Clark BJ; Paridon S; McCrindle BW; Wiegers SE; Araujo L; Vohra Y; Defesche JC; Wilson JM; Rader DJ
    Am J Cardiol; 2008 Dec; 102(11):1438-43. PubMed ID: 19026292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE; Vessby B; Wikström B; Danielson BG
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronary ectasia in a homozygous patient with familial hypercholesterolemia.
    Mabuchi H; Michishita I; Sakai Y; Sakai T; Ikawa T; Genda A; Takeda R
    Atherosclerosis; 1986 Jan; 59(1):43-6. PubMed ID: 3947422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of orthotopic liver transplant in the treatment of homozygous familial hypercholesterolemia.
    Castilla Cabezas JA; López-Cillero P; Jiménez J; Fraga E; Arizón JM; Briceño J; Solórzano G; De la Mata M; Pera C
    Rev Esp Enferm Dig; 2000 Sep; 92(9):601-8. PubMed ID: 11138242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C].
    Yu L; Heere-Ress E; Boucher B; Defesche JC; Kastelein J; Lavoie MA; Genest J
    Atherosclerosis; 1999 Sep; 146(1):125-31. PubMed ID: 10487495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
    Blaha M; Lanska M; Blaha V; Boudys L; Zak P
    Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
    Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
    Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of homozygous familial hypercholesterolemia with an atypical phenotype and delayed clinical symptoms.
    Kyselak O; Soska V; Kovar J; Tichy L; Grombirikova H; Hubacek JA; Freiberger T
    J Clin Lipidol; 2021; 15(3):435-440. PubMed ID: 33975813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis.
    Stefanutti C; Morozzi C; Di Giacomo S; Sovrano B; Mesce D; Grossi A
    J Clin Lipidol; 2016; 10(4):782-789. PubMed ID: 27578108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical observations and treatment of pediatric homozygous familial hypercholesterolemia due to a low-density lipoprotein receptor defect.
    Huang CH; Chiu PC; Liu HC; Lu YH; Huang JK; Charng MJ; Niu DM
    J Clin Lipidol; 2015; 9(2):234-40. PubMed ID: 25911080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis.
    Uauy R; Zwiener RJ; Phillips MJ; Petruska ML; Bilheimer DW
    J Pediatr; 1992 Jun; 120(6):892-8. PubMed ID: 1593349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-density lipoprotein apheresis in homozygous familial hypercholesterolemia.
    Mora C; Teruel JL; Navarro JF
    Am J Cardiol; 2001 Jul; 88(2):202-3. PubMed ID: 11463060
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.
    Alonso R; Díaz-Díaz JL; Arrieta F; Fuentes-Jiménez F; de Andrés R; Saenz P; Ariceta G; Vidal-Pardo JI; Almagro F; Argueso R; Prieto-Matos P; Miramontes JP; Pintó X; Rodriguez-Urrego J; Perez de Isla L; Mata P
    J Clin Lipidol; 2016; 10(4):953-961. PubMed ID: 27578128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.